FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 8 mg/250 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 16 mg/250 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 3 g/3 L | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 8 mg/250 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 8 mg/250 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 4 mg/250 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 4 mg/250 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 4 mg/250 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 16 mg/250 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 30 U/500 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 30 U/500 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 30 U/500 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 15000 U/1500 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 22500 U/2250 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 22500 U/2250 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 20 U/1000 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 20 U/1000 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 15 g/1500 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 300 mg/3000 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 1 mg/10 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 40 mg/250 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 800 ug/10 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 120 mg/3000 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 50 mg/250 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 20 mg/250 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 500 mg/5000 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 240 mg/3000 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 1 mg/10 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 400 ug/10 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 1 mg/10 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 30 g/3000 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 30 g/3000 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 100 mg/10 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 20 mg/5 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 20 mg/5 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 20 mg/5 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 60 g/3000 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 20 mg/5 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 20 mg/10 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.75 g/250 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.5 g/250 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1 g/250 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.25 g/250 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 300 g/3000 mL | 2023-1 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.5 g/500 mL | 2023-1 | source_no_ndc | 2026-11-10 |